SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NTII - Miscellaneous
An SI Board Since August 2001
Posts SubjectMarks Bans Symbol
1296 22 0 NTII
Emcee:  John McCarthy Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
12212005 - New Forest Patent Application - APP Use of 1-aminocyclohexane derivativeJohn McCarthy-9/26/2005
12202005 - "have lost weight easily" SEVERE EDIT - link at bottom Worse,John McCarthy-9/26/2005
12192005 - Corcept Closes Enrollment of Proof of Concept Clinical Study Evaluating CJohn McCarthy-9/26/2005
12182005 - NMDA Antagonists and Neuropathic Pain - Multiple Drug Targets and MultiplJohn McCarthy-9/26/2005
12172005 - Neurologix announces positive results of gene therapy clinical trial in PJohn McCarthy-9/26/2005
12162005 - CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical company engaged in John McCarthy-9/25/2005
12152005 - Reinstatement of Morphine-Conditioned Reward is Blocked by Memantine PioJohn McCarthy-9/25/2005
12142005 - The NMDA antagonist memantine affects training induced motor cortex plastJohn McCarthy-9/25/2005
12132005 - NATURE - Memantine reduces hematoma expansion in experimental intracerebrJohn McCarthy-9/25/2005
12122005 - NTI Sells Xerecept Rights To Celtic Pharma For $48M By Karen Pihl-CareyJohn McCarthy-9/21/2005
1211Thanks John...<i>Body weight decreased markedly within a few days.</i&gzeta1961-9/20/2005
1210<<<<<<<<<< Re: memantine and food binging..if you John McCarthy-9/20/2005
1209Message 21719281 John, Marc knows the details of Viprinex P3 at his finger tipszeta1961-9/20/2005
1208Hi Zita FWIW (*please* feel free to comment/disagree/etc) After the $33 milJohn McCarthy-9/20/2005
1207Thanks rk..Marc and I have disagreed on this one:-) I had the opportunity to rzeta1961-9/20/2005
1206Got rid of a stale and old program and more importantly the spend associated witrkrw-9/20/2005
1205John, NTII sold Xerecept rights today..what's your take? Tia, Elisabeth{we zeta1961-9/20/2005
12042005 - Ongoing Memantine Trials by Forest Labs (from their Web Site) Study ID:John McCarthy-9/14/2005
12032005 - Old drug shows new promise for Huntington's Disease ***************John McCarthy-9/14/2005
12022005 - Some recent posts from an AD board about Namenda (note - there are negatJohn McCarthy-9/14/2005
12012005 - Memantine and Binge Eating Disorders 1: Econ Hum Biol. 2005 Jul;3(2):32John McCarthy-9/14/2005
12002005 - Comparison of donepezil and memantine for protective effect against amyloJohn McCarthy-9/13/2005
11992005 - University Of Chicago Researchers Find Human Brain Still Evolving HumanJohn McCarthy-9/12/2005
11982005 - Power3 Medical Files Provisional Patent Application for Biomarker-based MJohn McCarthy-9/7/2005
11972005 - Aeolus Pharmaceuticals Reports Positive Safety Results from Completed PhaJohn McCarthy-9/7/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News